{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:01:16Z","timestamp":1791169276282,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T00:00:00Z","timestamp":1301961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The elucidation of the genes leading to selected immune defects has accelerated our understanding of the molecular basis of tolerance in autoimmunity disorders. Mutations in genes of the immune system are known to lead to a catalogue of functional deficits, including loss of activation-induced Fas-mediated apoptosis, an inability to remove self-reactive T and\/or B cells and insufficient numbers or functions of regulatory T cells. In most cases, microbial antigen stimulation occurs simultaneously, leading to further inflammatory responses. In each case, probing the molecular pathways involved in these primary immune defects has led to a better understanding of autoimmune diseases in general. While subjects with X-linked agammaglobulinaemia are almost devoid of autoimmune diseases, B cells which are present, but dysfunctional in other defects, lead to a significant incidence of autoimmune disease. Autoimmunity is also particularly common in the antibody deficiency states. Although organ-based autoimmunity also occurs, for unclear reasons the main conditions are immune thrombocytopenia purpura and autoimmune haemolytic anaemia. The common variable immune deficiency subjects most afflicted by these cytopenias are those with specific peripheral blood memory B cell phenotypes. B cells of these subjects have a retained autoimmune potential, lack of somatic hypermutation, profound loss of proliferative potential, accelerated apoptosis and loss of normal Toll-like receptor signalling. Treatment with high-dose immunoglobulin and\/or steroids can be helpful, while rituximab provides benefits in the treatment of refractory cytopenias with apparently little risk, even with repeated use, due to ongoing immune globulin therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04388.x","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T13:13:38Z","timestamp":1302009218000},"page":"6-11","source":"Crossref","is-referenced-by-count":60,"title":["Autoimmunity in primary immune deficiency: taking lessons from our patients"],"prefix":"10.1093","volume":"164","author":[{"given":"C","family":"Cunningham-Rundles","sequence":"first","affiliation":[{"name":"Mount Sinai School of Medicine, Department of Medicine, New York City, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,5]]},"reference":[{"key":"2021122708481371900_b1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.coi.2009.08.007","article-title":"AIRE in the thymus and beyond","volume":"21","author":"Gardner","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"2021122708481371900_b2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2009-03-211029","article-title":"Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome","volume":"114","author":"Poliani","year":"2009","journal-title":"Blood"},{"key":"2021122708481371900_b3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis","volume":"15","author":"Gambineri","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"2021122708481371900_b4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12026-007-0022-2","article-title":"IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity","volume":"38","author":"Och","year":"2007","journal-title":"Immunol Res"},{"issue":"1","key":"2021122708481371900_b5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s10875-008-9176-5","article-title":"Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED","volume":"28","author":"Moraes-Vasconcelos","year":"2008","journal-title":"J Clin Immunol"},{"key":"2021122708481371900_b6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"2021122708481371900_b7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.21.2.202","article-title":"Significance of the simultaneous occurrence of connective tissue disease and agammaglobulinaemia","volume":"21","author":"Rotstein","year":"1962","journal-title":"Ann Rheum Dis"},{"key":"2021122708481371900_b8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J Pediatr"},{"key":"2021122708481371900_b9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Balt)"},{"key":"2021122708481371900_b10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20040920","article-title":"Bruton's tyrosine kinase is essential for human B cell tolerance","volume":"200","author":"Ng","year":"2004","journal-title":"J Exp Med"},{"key":"2021122708481371900_b11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.20062287","article-title":"CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance","volume":"204","author":"Herve","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708481371900_b12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.immuni.2008.09.015","article-title":"IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans","volume":"29","author":"Isnardi","year":"2008","journal-title":"Immunity"},{"key":"2021122708481371900_b13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11882-001-0027-1","article-title":"Common variable immunodeficiency","volume":"1","author":"Cunningham-Rundles","year":"2001","journal-title":"Curr Allergy Asthma Rep"},{"key":"2021122708481371900_b14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122708481371900_b15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2021122708481371900_b16","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s10875-008-9182-7","article-title":"Autoimmune manifestations in common variable immunodeficiency","volume":"28","author":"Cunningham-Rundles","year":"2008","journal-title":"J Clin Immunol"},{"key":"2021122708481371900_b17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11882-009-0051-0","article-title":"Autoimmunity in common variable immunodeficiency","volume":"9","author":"Agarwal","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"2021122708481371900_b18","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.4049\/jimmunol.165.8.4725","article-title":"Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency","volume":"165","author":"Bonhomme","year":"2000","journal-title":"J Immunol"},{"key":"2021122708481371900_b19","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(\u2013)IgD(\u2013)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"2021122708481371900_b20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects","volume":"23","author":"Piqueras","year":"2003","journal-title":"J Clin Immunol"},{"key":"2021122708481371900_b21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"Sanchez-Ramon","year":"2008","journal-title":"Clin Immunol"},{"key":"2021122708481371900_b22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"2021122708481371900_b23","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21\u2013 human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"2021122708481371900_b24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"2021122708481371900_b25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"2021122708481371900_b26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency","volume":"39","author":"Pan-Hammarstrom","year":"2007","journal-title":"Nat Genet"},{"key":"2021122708481371900_b27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708481371900_b28","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"2021122708481371900_b29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1074-7613(03)00025-6","article-title":"Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor","volume":"18","author":"Seshasayee","year":"2003","journal-title":"Immunity"},{"key":"2021122708481371900_b30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1471-4906(00)01843-3","article-title":"The role of TALL-1 and APRIL in immune regulation","volume":"22","author":"Khare","year":"2001","journal-title":"Trends Immunol"},{"key":"2021122708481371900_b31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2007.04.012","article-title":"High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency","volume":"124","author":"Knight","year":"2007","journal-title":"Clin Immunol"},{"key":"2021122708481371900_b32","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.21138","article-title":"BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus","volume":"52","author":"Stohl","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021122708481371900_b33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000082106","article-title":"The BAFF\/APRIL system: an important player in systemic rheumatic diseases","volume":"8","author":"Mackay","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"2021122708481371900_b34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021122708481371900_b35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2249.2006.03314.x","article-title":"Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo","volume":"147","author":"Fevang","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2021122708481371900_b36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clim.2009.03.519","article-title":"Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with common variable immunodeficiency: a link to autoimmunity?","volume":"132","author":"Genre","year":"2009","journal-title":"Clin Immunol"},{"key":"2021122708481371900_b37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clim.2008.12.006","article-title":"Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease","volume":"131","author":"Yu","year":"2009","journal-title":"Clin Immunol"},{"key":"2021122708481371900_b38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04388.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/164\/Supplement_2\/6\/41909057\/j.1365-2249.2011.04388.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/164\/Supplement_2\/6\/41909057\/j.1365-2249.2011.04388.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:23:17Z","timestamp":1641054197000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/164\/Supplement_2\/6\/6438937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,5]]},"references-count":38,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2011,4,5]]},"published-print":{"date-parts":[[2011,4,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04388.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,6]]},"published":{"date-parts":[[2011,4,5]]}}}